Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3973190
Max Phase: Preclinical
Molecular Formula: C24H25F3N6O2
Molecular Weight: 486.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3973190
Max Phase: Preclinical
Molecular Formula: C24H25F3N6O2
Molecular Weight: 486.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(C)C)cc3OC)ncc2C(F)(F)F)c1
Standard InChI: InChI=1S/C24H25F3N6O2/c1-5-21(34)30-15-7-6-8-16(11-15)31-22-18(24(25,26)27)13-28-23(33-22)32-19-10-9-17(29-14(2)3)12-20(19)35-4/h5-14,29H,1H2,2-4H3,(H,30,34)(H2,28,31,32,33)
Standard InChI Key: VVIRSVARIBXZHS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 486.50 | Molecular Weight (Monoisotopic): 486.1991 | AlogP: 5.94 | #Rotatable Bonds: 9 |
Polar Surface Area: 100.20 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.64 | CX Basic pKa: 5.74 | CX LogP: 5.16 | CX LogD: 5.15 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.28 | Np Likeness Score: -1.33 |
1. (2016) Mutant-selective EGFR inhibitors and uses thereof, |
Source(1):